Logo

European Patent Office Reinstates ABI’s PCR Thermal Cycler IP

Jul 17, 2006
NEW YORK (GenomeWeb News) - Applied Biosystems today said that the Technical Board of Appeal of the European Patent Office has reinstated its patent covering real-time PCR thermal cycler technology.
 
The ruling overturns a December 2004 decision by the Opposition Division to revoke the patent for "alleged lack of novelty," ABI said. The case will be returned to the Opposition Division for review of other issues.
 
The patent is European Patent No. 872562.
 
Additional details were not disclosed.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.